Skip to content

Top alternative

Readers comparing prepaid, dose-independent compounded-injection plans who can confirm their state eligibility and the complete payment terms.

semaglutide
From $79/mo12-month prepay
tirzepatide
From $129/mo12-month prepay
Plan details

semaglutide: From $79/mo (12-month plan paid in full; confirm the complete charge before paying; no month-to-month price established; same price at every dose according to the FAQ; compounded injectable)

tirzepatide: From $129/mo (12-month plan paid in full; confirm the complete charge before paying; no month-to-month price established; same price at every dose according to the FAQ; compounded injectable)

The advertised starting $79/$129 monthly equivalents require a 12-month plan paid in full; no month-to-month price was established

Read the CoreAge Rx review →

More alternatives to compare

If cost is your reason for switching, use our guide to GLP-1 costs without insurance to put medication charges, fees and refill intervals on the same footing.

  • 82/100
    B−

    Lowest-priced compounded semaglutide on a 3-month commitment, with brand-name Ozempic/Zepbound also available. Our Pallas Health vs Get Thin MD comparison sets the two side by side on cost and state coverage.

    semaglutide
    $199/mo
    tirzepatide
    $299/mo
    Plan details

    semaglutide: $199/mo (compounded)

    tirzepatide: $299/mo (compounded)

    Read the Get Thin MD review →
  • 79/100
    C+

    Patients wanting a wide GLP-1 menu (branded or compounded) from a LegitScript-verified platform. Our Pallas Health vs Heally comparison sets the two side by side on cost and state coverage.

    semaglutide
    From $199/molowest dose rung
    tirzepatide
    $299/mobrand-name
    Plan details

    semaglutide: $199/mo (starting dose, compounded)

    tirzepatide: $299/mo (starting dose, brand-name)

    Read the Heally review →
  • #116
    Hers
    76/100
    C

    Mainstream telehealth GLP-1 access. Our Pallas Health vs Hers comparison sets the two side by side on cost and state coverage.

    semaglutide
    From $199/molowest dose rung
    tirzepatide
    $299/mobrand-name

    FDAWarning letter issued to Hims & Hers Health, Inc. dba Hers in September 2025. See the FDA warning-letter database.

    Plan details

    semaglutide: $199/mo (starting dose, compounded)

    tirzepatide: $299/mo (starting dose, plus a separate fee, brand-name)

    Limited public information on program details

    Read the Hers review →
  • 89/100
    B+

    Someone who wants a low compounded price without prepaying a year, and the option to move to brand tirzepatide on the same account. Our Pallas Health vs Vytora Health comparison sets the two side by side on cost and state coverage.

    semaglutide
    $179/mo
    tirzepatide
    $249/mo
    Plan details

    semaglutide: $179/mo month-to-month; $149/mo on a 3-month plan ($447 every 3 months); same price at every dose; compounded injectable

    tirzepatide: $249/mo month-to-month; $199/mo on a 3-month plan ($599 every 3 months); same price at every dose; compounded injectable

    Injectable only — no oral route

    Read the Vytora Health review →
  • #166
    Medro
    71/100
    C

    Compounded or brand semaglutide/tirzepatide with transparent tiered pricing and no membership, all 50 states. Our Pallas Health vs Medro comparison sets the two side by side on cost and state coverage.

    semaglutide
    $199/mo
    tirzepatide
    $299/mo
    Plan details

    semaglutide: $199/mo (compounded)

    tirzepatide: $299/mo (compounded)

    Does not name its compounding pharmacy or its clinical partner medical group, so the fulfillment chain is not verifiable.

    Read the Medro review →

More Pallas Health head-to-heads

See the full comparison hub or the complete ranking of 545 providers.

Pricing and verification reflect public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Not medical advice; see our disclosure.